Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 5/20 | 0.36 |
| ▸ | CA6 | P23280 | 5/20 | 0.36 |
| ▸ | CA7 | P43166 | 5/20 | 0.36 |
| ▸ | CA9 | Q16790 | 5/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA4 | P22748 | 4/20 | 0.36 |
| ▸ | CA5A | P35218 | 4/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.36 |
| ▸ | CASP2 | P42575 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | F13A1 | P00488 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | THPO | P40225 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11521746 | 0.92 | CYP2C19 (0.52) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL7524602 | 0.90 | CYP2C9 (0.45) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL20675950 | 0.89 | ALOX15 (0.43) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL17124821 | 0.89 | CYP2C19 (0.45) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL11209433 | 0.88 | TDP1 (0.54) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL4745524 | 0.88 | CYP2C9 (0.41) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL323203 | 0.87 | CYP2C19 (0.56) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL12556866 | 0.87 | CYP2C19 (0.56) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL16672009 | 0.86 | CYP2C19 (0.47) | CYP2C19CYP2C9TDP1CA12CA6 | |
| SCHEMBL12598532 | 0.86 | CYP2C9 (0.40) | CYP2C19CYP2C9TDP1CA12CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200123312-A1 | POLYAMIDES AND AMIDOAMINES DERIVED FROM HYROXYALKYLPOLYAMINES: EPOXY CURING AGENTS WITH IMPROVED PROPERTIES | EVONIK OPERATIONS GMBH (DE) | 2020-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200123312-A1 | POLYAMIDES AND AMIDOAMINES DERIVED FROM HYROXYALKYLPOLYAMINES: EPOXY CURING AGENTS WITH IMPROVED PROPERTIES | PAM, HNMT, NAAA | CYP2C19 1472/4885CYP2C9 1741/4885TDP1 744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.